FDA Approves Unknown Drug — SANDOZ

# Sandoz Receives FDA Approval for Generic Drug Sandoz has received FDA approval for a generic drug formulation under ANDA040194, expanding the company's portfolio in the competitive generic pharmaceuticals market and positioning it to capture market share as patent protections expire on the reference product. The approval strengthens Sandoz's generic drug pipeline during a period of significant growth in the U.S. generic drug sector.